Inhaled Niclosamide Inhibits Viral Replication of the Omicron Variant of SARS-CoV-2 February 24, 2022 Auto Bot News 0 TFF Pharmaceuticals announces findings that inhaled niclosamide significantly inhibits viral replication of the Omicron variant of SARS-CoV-2.
